Personalised medicine to relieve the health serviceSmaller patient groups and targeted treatments are the future of cancer care in Norway.
Advancing precision cancer medicine via European collaborationLearn more about the EU-funded Norwegian initiatives PCM4EU and PRIME-ROSE, and the Norwegian MATRIX Centre. Two Norwegian EU-funded...
Success criteria for industry-sponsored clinical trialsThe third educational seminar in the clinical trials meeting series arranged by CONNECT Working Group 2 took place via Zoom on 13 February.
CONNECT seminar: investigator-initiated clinical trialsHow can researchers have successful collaborations with industry in clinical studies? This was a central question at a recent CONNECT semina
Inclusion of clinical opinions in economic evaluationsHow can clinicians be more involved in healthcare decision-making?
Kicking off the Clinical Trials meeting seriesIndustry-sponsored clinical studies in Norway were in focus at the kick-off meeting for a new meeting series hosted by CONNECT Working Group
The future of precision cancer medicineThe first national initiatives for precision cancer medicine have successfully taken shape in Norway, but what has been achieved and what do
CONNECT seminar on Digital Pathology and AIExperts from regional, national and international groups shared their perspectives on digital pathology and artificial intelligence (AI)...